Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00078767Phase 3Completed
Phase 3, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing TF-CBT + sertraline with TF-CBT + placebo (2 arms). Primary endpoint: Kiddie-Sads-Present and Lifetime Scale for PTSD up to 39 months. Started Apr 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00078767.